{"id":4489,"date":"2018-01-15T07:19:12","date_gmt":"2018-01-15T06:19:12","guid":{"rendered":"http:\/\/kreftgenomikk.w.uib.no\/?p=4489"},"modified":"2018-09-06T10:33:25","modified_gmt":"2018-09-06T09:33:25","slug":"doktorgrader","status":"publish","type":"post","link":"https:\/\/kreftgenomikk.w.uib.no\/en\/doktorgrader\/","title":{"rendered":"NCGC PhD dissertations"},"content":{"rendered":"<p>[et_pb_section admin_label=&#8221;Seksjon&#8221; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221;][et_pb_fullwidth_post_title admin_label=&#8221;Fullbreddes innleggstittel&#8221; title=&#8221;on&#8221; meta=&#8221;off&#8221; author=&#8221;on&#8221; date=&#8221;on&#8221; categories=&#8221;on&#8221; comments=&#8221;on&#8221; featured_image=&#8221;on&#8221; featured_placement=&#8221;background&#8221; parallax_effect=&#8221;off&#8221; parallax_method=&#8221;on&#8221; text_orientation=&#8221;right&#8221; text_color=&#8221;light&#8221; text_background=&#8221;on&#8221; text_bg_color=&#8221;rgba(21,150,137,0.9)&#8221; module_bg_color=&#8221;rgba(255,255,255,0)&#8221; title_font=&#8221;|on|||&#8221; title_font_size=&#8221;35px&#8221; title_all_caps=&#8221;off&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221; module_id=&#8221;header-image-and-text&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_fullwidth_post_title][\/et_pb_section][et_pb_section admin_label=&#8221;Seksjon&#8221; fullwidth=&#8221;off&#8221; specialty=&#8221;off&#8221;][et_pb_row admin_label=&#8221;Rad&#8221;][et_pb_column type=&#8221;2_3&#8243;][et_pb_text admin_label=&#8221;Tekst&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p class=\"ingress\">The NCGC grants \u00a0included three PhD projects, of which two are now completed. The theses will be available on<span lang=\"EN-US\">\u00a0<a href=\"https:\/\/www.duo.uio.no\/discover?filtertype=type&amp;filter_relational_operator=equals&amp;filter=Doktoravhandling\">duo.uio.no<\/a> when all results have been published in scientific journals. Our PhD in health economy is not yet finished.<\/span><\/p>\n<p class=\"ingress\"><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-5523 size-full\" src=\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/Robert.jpg\" alt=\"\" width=\"123\" height=\"164\" \/><\/span><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-5524 size-medium\" src=\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/HanesThesis-156x225.jpg\" alt=\"\" width=\"156\" height=\"225\" srcset=\"https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/HanesThesis-156x225.jpg 156w, https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/HanesThesis-768x1108.jpg 768w, https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/HanesThesis-243x350.jpg 243w, https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/HanesThesis.jpg 967w\" sizes=\"auto, (max-width: 156px) 100vw, 156px\" \/><\/span>MSc <strong>Robert Hanes<\/strong> at the Dept of \u00a0Tumour Biology, Institute for cancer Research (OUS &#8211; Radiumhospitalet) defended his thesis &#8220;<span lang=\"EN-US\">Precision medicine for the treatment of a highly malignant and resistant type of liposarcoma&#8221; 25\/1-18. Opponents were\u00a0<\/span>Dr. Sandra Strauss, University College London (UCL) Cancer Institute, London, Group leader Antoni Wiedlocha, Oslo University Hospital, and Professor emeritus Tom Kristensen, University of Oslo.<\/p>\n<p>&nbsp;<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-5525 size-full\" src=\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/isabelle.jpg\" alt=\"\" width=\"150\" height=\"156\" \/><a href=\"http:\/\/hdl.handle.net\/10852\/61642\"><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-5526 size-medium\" src=\"https:\/\/kreftgenomikk.no\/files\/2018\/01\/IsabelleThesis-152x225.jpg\" alt=\"\" width=\"152\" height=\"225\" srcset=\"https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/IsabelleThesis-152x225.jpg 152w, https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/IsabelleThesis-768x1138.jpg 768w, https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/IsabelleThesis-236x350.jpg 236w, https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/01\/IsabelleThesis.jpg 943w\" sizes=\"auto, (max-width: 152px) 100vw, 152px\" \/><\/span><\/a>MA\u00a0<strong>Isabelle Sylvie Budin Lj\u00f8sne<\/strong> at the Institute for Healthe and Society (UiO) defended her\u00a0<a href=\"http:\/\/hdl.handle.net\/10852\/61642\">PhD thesis &#8220;Bringing personalized medicine to people&#8221;<\/a> 27\/4-18. Opponents were Dr. Eric Meslin, President and CEO, Council of Canadian Academies, Professor Effy Vayena, Institute of Translational Medicine, Eidgen\u00f6ssische Technische Hochschule (ETH) Z\u00fcrich, and Professor Emeritus Gerd Holmboe-Ottesen, Institutt for helse og samfunn, Universitetet i Oslo.<\/p>\n<p>You may read\u00a0<a href=\"https:\/\/forskning.no\/medisiner-forskningsetikk-genteknologi\/2018\/05\/faar-alle-tilgang-til-persontilpasset-medisin\">interview of Isabelle at Forskning.no (Norwegian)<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243;][et_pb_sidebar admin_label=&#8221;Nyhetsarkiv og konferanser&#8221; orientation=&#8221;left&#8221; area=&#8221;primary&#8221; background_layout=&#8221;light&#8221; remove_border=&#8221;off&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>[et_pb_section admin_label=&#8221;Seksjon&#8221; fullwidth=&#8221;on&#8221; specialty=&#8221;off&#8221;][et_pb_fullwidth_post_title admin_label=&#8221;Fullbreddes innleggstittel&#8221; title=&#8221;on&#8221; meta=&#8221;off&#8221; author=&#8221;on&#8221; date=&#8221;on&#8221;&#46;&#46;&#46;<\/p>\n","protected":false},"author":4078,"featured_media":5533,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[174711],"tags":[],"class_list":["post-4489","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-forside-6"],"_links":{"self":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/4489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/users\/4078"}],"replies":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=4489"}],"version-history":[{"count":22,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/4489\/revisions"}],"predecessor-version":[{"id":5721,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/4489\/revisions\/5721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/media\/5533"}],"wp:attachment":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=4489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=4489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=4489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}